BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28474330)

  • 1. Mucinous adenocarcinoma of the thymus: report of a case.
    Kinoshita F; Shoji F; Takada K; Toyokawa G; Okamoto T; Yano T; Oda Y; Maehara Y
    Gen Thorac Cardiovasc Surg; 2018 Feb; 66(2):111-115. PubMed ID: 28474330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucinous adenocarcinoma of the thymus: a case report.
    Seki E; Aoyama K; Ueda M; Haga T; Nakazato Y; Iijima M; Kojima M; Tanaka R
    J Thorac Oncol; 2008 Aug; 3(8):935-7. PubMed ID: 18670316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
    Shim HS; Kenudson M; Zheng Z; Liebers M; Cha YJ; Hoang Ho Q; Onozato M; Phi Le L; Heist RS; Iafrate AJ
    J Thorac Oncol; 2015 Aug; 10(8):1156-62. PubMed ID: 26200269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous adenocarcinoma arising from a residual supratentorial neurenteric cyst and expressing mutated KRAS: a case report.
    Rim HT; Song JH; Kim ES; Kwon MJ
    Hum Pathol; 2016 Dec; 58():146-151. PubMed ID: 27569299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung.
    Ueda D; Ito M; Tsutani Y; Giménez-Capitán A; Román-Lladó R; Pérez-Rosado A; Aguado C; Kushitani K; Miyata Y; Arihiro K; Molina-Vila MA; Rosell R; Takeshima Y; Okada M
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3709-3718. PubMed ID: 33796913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
    Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
    Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
    Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAS Mutation in Mucinous Carcinoma of the Ovary.
    Panyavaranant P; Teerapakpinyo C; Pohthipornthawat N; Oranratanaphan S; Shuangshoti S; Triratanachat S
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1127-1132. PubMed ID: 31030485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucinous adenocarcinoma of the thymus: a distinct variant of thymic carcinoma.
    Maeda D; Ota S; Ikeda S; Kawano R; Hata E; Nakajima J; Mori M; Fukayama M
    Lung Cancer; 2009 Apr; 64(1):22-7. PubMed ID: 18722686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial Adenocarcinomas With Significant Mucinous Differentiation: A Characterization of Intratumoral Heterogeneity of KRAS Mutations in Mucinous and Endometrioid Histologic Components.
    Jackson CL; Hang S; Hansen K; He M; Sung CJ; Quddus MR; Xiong M; Wang Y; Patel NR; Lawrence WD; Xiong J
    Int J Gynecol Cancer; 2018 Feb; 28(2):241-247. PubMed ID: 29303928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of EGFR and KRAS mutations in Japanese patients with lung adenocarcinoma with features of the mucinous subtype of bronchioloalveolar carcinoma.
    Hata A; Katakami N; Fujita S; Kaji R; Imai Y; Takahashi Y; Nishimura T; Tomii K; Ishihara K
    J Thorac Oncol; 2010 Aug; 5(8):1197-200. PubMed ID: 20661086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation.
    Ichinokawa H; Ishii G; Nagai K; Kawase A; Yoshida J; Nishimura M; Hishida T; Ogasawara N; Tsuchihara K; Ochiai A
    Hum Pathol; 2013 Dec; 44(12):2636-42. PubMed ID: 24119562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the thymus, enteric type: report of 2 cases, and proposal for a novel subtype of thymic carcinoma.
    Moser B; Schiefer AI; Janik S; Marx A; Prosch H; Pohl W; Neudert B; Scharrer A; Klepetko W; Müllauer L
    Am J Surg Pathol; 2015 Apr; 39(4):541-8. PubMed ID: 25517960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
    Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y
    World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [KRAS mutations analysis in mucinous epithelial lesions of the endometrium].
    Zheng XZ; Zhan Y; Ma JH; Xu HW; Zhi WX; Chen TB; Qin XY; Wang P; Zhang LH; Gu YC; Jin YL; Zhu L; Wu BQ
    Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):687-690. PubMed ID: 30220122
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucinous Adenocarcinoma With Intrapulmonary Metastasis Harboring KRAS and GNAS Mutations Arising in Congenital Pulmonary Airway Malformation.
    de Cordova XF; Wang H; Mehrad M; Eisenberg R; Johnson J; Wei Q; Borinstein S; Danko ME; Liang J
    Am J Clin Pathol; 2021 Jul; 156(2):313-319. PubMed ID: 33609098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HNF4α as a marker for invasive mucinous adenocarcinoma of the lung.
    Sugano M; Nagasaka T; Sasaki E; Murakami Y; Hosoda W; Hida T; Mitsudomi T; Yatabe Y
    Am J Surg Pathol; 2013 Feb; 37(2):211-8. PubMed ID: 23108025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Thymic Mucinous Adenocarcinoma with Extensive Punctate and Amorphous Calcifications: A Case Report.
    Cho H; Park J; Shin KM; Park SY; Park B; Jeong JY; Kim JH
    Curr Med Imaging; 2024; 20():e060623217707. PubMed ID: 37282659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucinous cystic tumor with CK20 and CDX2 expression of the thymus: Is this a benign counterpart of adenocarcinoma of the thymus, enteric type?
    Akiba J; Harada H; Yokoyama S; Hashiguchi T; Kawahara A; Mitsuoka M; Takamori S; Yano H
    Pathol Int; 2016 Jan; 66(1):29-33. PubMed ID: 26581569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.
    Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR
    Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.